Welcome to Shandong Sinobioway Biomedical Co., Ltd.
CN | EN

Home>About us > Development

Development History

  • 2009 October 26Wanchang Science and Technology Development Co., Ltd. Zibo approved by the Shandong Provincial Department of Commerce to Lu Business Foreign Investment [2009] No. 289 (now changed from foreign investment to domestic-funded enterprises)

  • 2009 November 16Wanchang Technology Co., Ltd. Zibo in Shandong Province Administration for Industry and Commerce registered capital of 58 million yuan

  • 2011 April 22Wanchang Technology Co., Ltd. Zibo in Shandong Province Administration for Industry and Commerce registered capital of 58 million yuan

  • 2011 May 10The Company actually issued 27.08 million ordinary shares of RMB, after deducting various issuance costs, the net proceeds were actually RMB 471,272,858.31. After the initial public offering, the total share capital of the Company was 108.28 million shares

  • 2011 May 20As approved by the Shenzhen Stock Exchange (Stock Code: Zibo Wanchang Science and Technology Co., Ltd., Notice of Listing and Trading of RMB Ordinary Shares) (Shenzheng Shang [2011] No. 154), the RMB ordinary shares issued by the Company were listed on the SME Board of the Shenzhen Stock Exchange , The stock referred to as "Wanchang Technology", the stock code 002581

  • 2015 July 31The issuance of shares by the Company and the cash purchase of assets and related party transactions were approved by the China Securities Regulatory Commission (Approval Number: Zheng Jian Xu Ke [2015] No. 1853)

  • 2015 1The reorganization of the underlying assets involved in the unnamed Pharmaceutical Co., Ltd. completed the transfer of 100% equity transfer

  • 2015 September 15The newly increased RMB ordinary shares (A shares) 378,207,586 shares involved in this restructuring were registered and confirmed at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch

  • 2015 September 24The new shares are listed on the Shenzhen Stock Exchange. The shares are tradable shares subject to trading moratorium

  • 2015 October 19Company name changed to "Shandong Sinobioway Biomedical Co., Ltd.", stock abbreviation changed to "unnamed medicine." Upon completion of this transaction, Beida Bioengineering Group Co., Ltd. held approximately 26.38% of the shares of the Company and became the controlling shareholder of the Company